EPM
ASPX

Equitec Proprietary Markets’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Equitec Proprietary Markets’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-900
Closed -$90K – 205
2015
Q1 		$90K Buy
+900
New +$60K 0.01% 115

Equitec Proprietary Markets's ASPX Position: Q2 2015 in Review

Equitec Proprietary Markets sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 900 shares — an estimated $90K sold.

Equitec Proprietary Markets first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $90K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Equitec Proprietary Markets reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Equitec Proprietary Markets sold 900 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $90K.
  • Equitec Proprietary Markets first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Equitec Proprietary Markets's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $90K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Equitec Proprietary Markets's 13F filing for Q2 2015, filed 5 Aug 2015.